Datasets:
congtri
/
ReadingBank

Dataset card Data Studio Files
xet
Community
1
text
stringlengths
47
113
35 of 427.5100 237.2408 437.5064 251.7819 612.0 792.0
35 action 367.3900 249.2708 398.4153 263.8119 612.0 792.0
35 Is 471.9400 207.0008 480.6913 221.5419 612.0 792.0
35 the 483.5800 207.0008 499.3883 221.5419 612.0 792.0
35 molecule 471.9400 219.1208 517.5592 233.6619 612.0 792.0
35 currently 471.9400 231.1208 516.9150 245.6619 612.0 792.0
35 under 471.9400 243.2708 501.2334 257.8119 612.0 792.0
35 development 471.9400 255.3908 536.8734 269.9319 612.0 792.0
35 for 471.9400 267.3908 485.9848 281.9319 612.0 792.0
35 type 488.8600 267.3908 510.4129 281.9319 612.0 792.0
35 2 513.3170 267.3908 519.1883 281.9319 612.0 792.0
35 diabetes? 471.9400 279.5108 520.9912 294.0519 612.0 792.0
35 Novo 78.0240 436.0780 102.5971 450.5874 612.0 792.0
35 Nordisk 105.5000 436.0780 141.0238 450.5874 612.0 792.0
35 Semaglutide 179.0600 315.5780 237.4462 330.0874 612.0 792.0
35 Phase 280.2500 315.5780 310.1031 330.0874 612.0 792.0
35 II 313.0100 315.5780 318.8257 330.0874 612.0 792.0
35 Glucagon-like 367.3900 303.5780 431.6889 318.0874 612.0 792.0
35 peptide 367.3900 315.5780 401.9318 330.0874 612.0 792.0
35 1 404.8300 315.5780 410.7014 330.0874 612.0 792.0
35 (GLP-1) 413.5900 315.5780 450.9378 330.0874 612.0 792.0
35 receptor 367.3900 327.6980 406.0924 342.2074 612.0 792.0
35 agonist 408.9100 327.6980 442.7865 342.2074 612.0 792.0
35 Yes 471.9400 315.5780 490.0504 330.0874 612.0 792.0
35 Tri-agonist 179.0600 369.8180 228.8065 384.3275 612.0 792.0
35 1706/NN9423 179.0600 381.9380 243.9301 396.4474 612.0 792.0
35 Phase 280.2500 375.9380 310.1031 390.4474 612.0 792.0
35 I 313.0100 375.9380 315.9457 390.4474 612.0 792.0
35 Triple 367.3900 351.6980 393.7478 366.2074 612.0 792.0
35 agonist 396.6700 351.6980 430.5465 366.2074 612.0 792.0
35 of 433.3900 351.6980 442.2057 366.2074 612.0 792.0
35 GLP-1, 367.3900 363.8180 400.7970 378.3275 612.0 792.0
35 gastric 403.6377 363.8180 434.5996 378.3275 612.0 792.0
35 inhibitory 367.3900 375.9380 409.4928 390.4474 612.0 792.0
35 peptide 412.2700 375.9380 446.9279 390.4474 612.0 792.0
35 (GIP) 367.3900 387.9380 392.5017 402.4474 612.0 792.0
35 and 395.3500 387.9380 412.9814 402.4474 612.0 792.0
35 glucagon 415.8700 387.9380 458.5747 402.4474 612.0 792.0
35 (GCG) 367.3900 400.0580 398.3836 414.5674 612.0 792.0
35 receptors 401.2348 400.0580 445.1644 414.5674 612.0 792.0
35 No 471.9400 375.9380 485.4914 390.4474 612.0 792.0
35 AM833/NN9838 179.0600 424.0780 253.8882 438.5874 612.0 792.0
35 Phase 280.2500 424.0780 310.1031 438.5874 612.0 792.0
35 I 313.0100 424.0780 315.9457 438.5874 612.0 792.0
35 Amylin 367.3900 424.0780 399.0278 438.5874 612.0 792.0
35 analogue 401.9212 424.0780 445.0800 438.5874 612.0 792.0
35 No 471.9400 424.0780 485.4914 438.5874 612.0 792.0
35 G530S/NN9030 179.0600 448.1980 253.2863 462.7074 612.0 792.0
35 Phase 280.2500 448.1980 310.1031 462.7074 612.0 792.0
35 I 313.0100 448.1980 315.9457 462.7074 612.0 792.0
35 Glucagon 367.3900 448.1980 412.4707 462.7074 612.0 792.0
35 analogue 415.3900 448.1980 458.5488 462.7074 612.0 792.0
35 No 471.9400 448.1980 485.4914 462.7074 612.0 792.0
35 FGF21 179.0600 472.3180 211.8065 486.8275 612.0 792.0
35 Obesity/NN9499 179.0600 484.3180 256.1903 498.8275 612.0 792.0
35 Phase 280.2500 478.3180 310.1031 492.8275 612.0 792.0
35 I 313.0100 478.3180 315.9457 492.8275 612.0 792.0
35 Fibroblast 367.3900 472.3180 413.6112 486.8275 612.0 792.0
35 growth 416.4700 472.3180 448.0233 486.8275 612.0 792.0
35 factor 367.3900 484.3180 393.8111 498.8275 612.0 792.0
35 21 396.6700 484.3180 408.2966 498.8275 612.0 792.0
35 analogue 411.1900 484.3180 454.4756 498.8275 612.0 792.0
35 No 471.9400 478.3180 485.4914 492.8275 612.0 792.0
35 GG-co-agonist 179.0600 514.4380 247.5332 528.9475 612.0 792.0
35 1177/NN9277 179.0600 526.5580 243.9301 541.0675 612.0 792.0
35 Phase 280.2500 520.5580 310.1031 535.0675 612.0 792.0
35 I 313.0100 520.5580 315.9457 535.0675 612.0 792.0
35 Dual 367.3900 508.4380 389.0381 522.9475 612.0 792.0
35 agonist 391.9900 508.4380 425.8665 522.9475 612.0 792.0
35 of 428.7100 508.4380 437.5257 522.9475 612.0 792.0
35 GLP-1 367.3900 520.5580 397.8614 535.0675 612.0 792.0
35 and 400.7500 520.5580 418.2585 535.0675 612.0 792.0
35 GCG 421.1500 520.5580 445.1951 535.0675 612.0 792.0
35 receptors 367.3900 532.5580 411.3196 547.0675 612.0 792.0
35 No 471.9400 520.5580 485.4914 535.0675 612.0 792.0
35 PYY 179.0600 562.6780 200.1272 577.1875 612.0 792.0
35 1562/NN9747 202.9256 562.6780 267.8275 577.1875 612.0 792.0
35 Phase 280.2500 562.6780 310.1031 577.1875 612.0 792.0
35 I 313.0100 562.6780 315.9457 577.1875 612.0 792.0
35 Peptide 367.3900 556.6780 403.1040 571.1875 612.0 792.0
35 YY 405.9974 556.6780 420.0000 571.1875 612.0 792.0
35 hormone 367.3900 568.6780 408.8909 583.1875 612.0 792.0
35 analogue 411.7900 568.6780 455.0650 583.1875 612.0 792.0
35 Yes 471.9400 562.6780 490.0504 577.1875 612.0 792.0
35 Johnson 78.0240 599.5480 117.8458 614.0575 612.0 792.0
35 & 120.7400 599.5480 127.7835 614.0575 612.0 792.0
35 Johnson 78.0240 611.6680 117.8458 626.1775 612.0 792.0
35 HM12525A/ 179.0600 592.8280 234.6478 607.3374 612.0 792.0
35 JNJ-64565111 179.0600 610.8280 247.4746 625.3374 612.0 792.0
35 Phase 280.2500 605.5480 310.1031 620.0575 612.0 792.0
35 I 313.0100 605.5480 315.9457 620.0575 612.0 792.0
35 Dual 367.3900 593.5480 389.0381 608.0575 612.0 792.0
35 agonist 391.9900 593.5480 425.8665 608.0575 612.0 792.0
35 of 428.7100 593.5480 437.5257 608.0575 612.0 792.0
35 GLP-1 367.3900 605.5480 397.8614 620.0575 612.0 792.0
35 and 400.7500 605.5480 418.2585 620.0575 612.0 792.0
35 GCG 421.1500 605.5480 445.1951 620.0575 612.0 792.0
35 receptors 367.3900 617.6680 411.3196 632.1775 612.0 792.0
35 Yes 471.9400 605.5480 490.0504 620.0575 612.0 792.0
35 Novartis 78.0240 654.5080 116.6314 669.0175 612.0 792.0